Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
CI-988
Description:
A chemical compound that acts as a selective antagonist of cholecystokinin-B, also called gastrin, receptors.
Primary topic:
Neuropeptides and Animal Physiology (36%)
Related topics:
Neuropeptides and Animal Physiology (36%),
Pain Mechanisms and Treatments (12%)
Wikidata ID:
wiki/Q5011453
OpenAlex ID:
keywords/ci-988
Evidence for an involvement of the brain cholecystokinin B receptor in anxiety.
1991
·
L Singh
, A S Lewis
, et al.
·
Proceedings of the National Academy of Sciences
·
218
Up-regulation of cholecystokinin in primary sensory neurons is associated with morphine insensitivity in experimental neuropathic pain in the rat
1993
·
X.-J. Xu
, M.J.C. Puke
, et al.
·
Neuroscience Letters
·
171
The behavioural properties of CI‐988, a selective cholecystokininB receptor antagonist
1991
·
Lakhbir Singh
, Mark J. Field
, et al.
·
British Journal of Pharmacology
·
146
Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviors in the rat mesolimbic pathway
1992
·
JN Crawley
·
Journal of Neuroscience
·
100
PDF
Acute Tolerance to Continuously Infused Alfentanil: The Role of Cholecystokinin and N-Methyl-d-Aspartate-Nitric Oxide Systems
2000
·
Igor Kissin
, Cheryl A. Bright
, et al.
·
Anesthesia & Analgesia
·
90
Influence of Gastrin on Human Astrocytic Tumor Cell Proliferation
1996
·
I. Camby
, I. Salmon
, et al.
·
JNCI Journal of the National Cancer Institute
·
88
A Double-Blind, Placebo-Controlled Study of a CCK-B Receptor Antagonist, CI-988, in Patients With Generalized Anxiety Disorder
1995
·
Judith Bammert Adams
, Robert E. Pyke
, et al.
·
Journal of Clinical Psychopharmacology
·
87
Heterogeneity of CCK-B receptors involved in animal models of anxiety
1994
·
M. Derrien
, I. McCort-Tranchepain
, et al.
·
Pharmacology Biochemistry and Behavior
·
86
The cholecystokinin-B receptor antagonist CI-988 failed to affect CCK-4 induced symptoms in panic disorder patients
1997
·
Harold J. G. M. van Megen
, Herman G. M. Westenberg
, et al.
·
Psychopharmacology
·
77
Effect of CI-988 on cholecystokinin tetrapeptide-induced panic symptoms in healthy volunteers
1995
·
Jacques Bradwejn
, Diana Koszycki
, et al.
·
Biological Psychiatry
·
75
CCK-A and CCK-B selective receptor agonists and antagonists modulate olfactory recognition in male rats
1994
·
M. Lemaire
, G. A. Böhme
, et al.
·
Psychopharmacology
·
68
Placebo-controlled trial of the CCK-B antagonist, CI-988, in panic disorder
1999
·
Atul C Pande
, Martha Greiner
, et al.
·
Biological Psychiatry
·
61
Evaluation of the effects of PD 134308 (CI-988), A CCK-B antagonist, on the punished responding of squirrel monkeys
1991
·
K.R. Powell
, J.E. Barrett
·
Neuropeptides
·
51
Second Generation “Peptoid” CCK-B Receptor Antagonists: Identification and Development ofN-(Adamantyloxycarbonyl)-α-methyl-(R)-tryptophan Derivative (CI-1015) with an Improved Pharmacokinetic Profile
1998
·
Bharat K. Trivedi
, Janak K. Padia
, et al.
·
Journal of Medicinal Chemistry
·
50
The influence of 5-hydroxytryptamine re-uptake blockade on CCK receptor antagonist effects in the rat elevated zero-maze
1994
·
Michael J. Bickerdike
, Charles A. Marsden
, et al.
·
European Journal of Pharmacology
·
46
The anxiolytics CI-988 and chlordiazepoxide fail to reduce immediate early gene mRNA stimulation following exposure to the rat elevated X-maze
1996
·
Gillian L. Hinks
, Pierre Brown
, et al.
·
European Journal of Pharmacology
·
45
Lack of effect of CCKB receptor antagonists in ethological and conditioned animal screens for anxiolytic drugs
1995
·
Gerard R. Dawson
, Nadia M. J. Rupniak
, et al.
·
Psychopharmacology
·
41
Dextromethorphan potentiates morphine antinociception, but does not reverse tolerance in rats
1996
·
Orsolya Hoffmann
, Zsuzsanna Wiesenfeld-Hallin
·
Neuroreport
·
40
The effect of CCKB/gastrin antagonists on stimulated gastric acid secretion in the anaesthetized rat
1991
·
N.J. Hayward
, M. Harding
, et al.
·
British Journal of Pharmacology
·
40
PDF
The antagonism of benzodiazepine withdrawal effects by the selective cholecystokininB receptor antagonist CI‐988
1992
·
Lakhbir Singh
, Mark J. Field
, et al.
·
British Journal of Pharmacology
·
36
PDF
Rationally designed dipeptoid analogs of cholecystokinin. A Free-Wilson/Fujita-Ban analysis of some .alpha.-methyltryptophan derivatives as cholecystokinin-B antagonists
1992
·
Michael Higginbottom
, Clare Kneen
, et al.
·
Journal of Medicinal Chemistry
·
34
Spinal effect of the cholecystokinin-B receptor antagonist CI-988 on hyperalgesia, allodynia and morphine-induced analgesia in diabetic and mononeuropathic rats
2000
·
Marie-Ange Coudoré-Civiale
, Christine Courteix
, et al.
·
Pain
·
33
Behavioral effects of CCKB receptor ligands in a validated simulation of panic anxiety in rats
1996
·
François Jenck
, James R. Martin
, et al.
·
European Neuropsychopharmacology
·
33
Effect of CCK receptor antagonists on the antinociceptive, reinforcing and gut motility properties of morphine
1996
·
L. Singh
, R.J. Oles
, et al.
·
British Journal of Pharmacology
·
31
PDF
The anxiogenic effects of CCK-4 in monkeys are reduced by CCK-B antagonists, benzodiazepines or adenosine A2 agonists
1992
·
R.M. Palmour
, J. Bradwejn
, et al.
·
European Neuropsychopharmacology
·
30
Show more works
View as search
Works count:
114
Citation count:
2,497
Year
Topic
Type